A detailed history of Saturna Capital Corp transactions in Amgen Inc stock. As of the latest transaction made, Saturna Capital Corp holds 141,262 shares of AMGN stock, worth $44.6 Million. This represents 0.59% of its overall portfolio holdings.

Number of Shares
141,262
Previous 463,967 69.55%
Holding current value
$44.6 Million
Previous $132 Million 66.54%
% of portfolio
0.59%
Previous 1.84%

Shares

22 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 31, 2024

SELL
$262.75 - $319.31 $84.8 Million - $103 Million
-322,705 Reduced 69.55%
141,262 $44.1 Million
Q4 2023

Feb 06, 2024

SELL
$255.7 - $288.46 $2.43 Million - $2.74 Million
-9,515 Reduced 2.01%
463,967 $134 Million
Q3 2023

Nov 14, 2023

SELL
$218.65 - $271.46 $4.62 Million - $5.74 Million
-21,140 Reduced 4.27%
473,482 $127 Million
Q2 2023

Aug 04, 2023

SELL
$214.27 - $253.37 $1.24 Million - $1.47 Million
-5,806 Reduced 1.16%
494,622 $110 Million
Q1 2023

May 15, 2023

BUY
$225.79 - $275.2 $7.9 Million - $9.63 Million
35,000 Added 7.52%
500,428 $121 Million
Q4 2022

Feb 09, 2023

SELL
$229.03 - $291.01 $25,651 - $32,593
-112 Reduced 0.02%
465,428 $122 Million
Q3 2022

Nov 10, 2022

BUY
$224.46 - $253.15 $23.8 Million - $26.9 Million
106,112 Added 29.52%
465,540 $105 Million
Q1 2022

May 10, 2022

BUY
$219.27 - $242.57 $12,059 - $13,341
55 Added 0.02%
359,428 $86.9 Million
Q4 2021

Feb 09, 2022

SELL
$198.88 - $227.6 $133,846 - $153,174
-673 Reduced 0.19%
359,373 $80.8 Million
Q3 2021

Nov 08, 2021

BUY
$212.27 - $248.7 $42,454 - $49,740
200 Added 0.06%
360,046 $73.2 Million
Q2 2021

Aug 11, 2021

SELL
$233.58 - $259.14 $87,592 - $97,177
-375 Reduced 0.1%
359,846 $87.7 Million
Q1 2021

May 14, 2021

SELL
$221.91 - $258.6 $6,879 - $8,016
-31 Reduced 0.01%
360,221 $89.6 Million
Q4 2020

Feb 12, 2021

SELL
$216.38 - $257.67 $23,801 - $28,343
-110 Reduced 0.03%
360,252 $82.8 Million
Q4 2019

Feb 13, 2020

SELL
$189.21 - $243.2 $3,784 - $4,864
-20 Reduced 0.01%
360,362 $86.9 Million
Q3 2019

Nov 14, 2019

SELL
$174.11 - $208.62 $32,732 - $39,220
-188 Reduced 0.05%
360,382 $69.7 Million
Q2 2019

Jul 31, 2019

SELL
$166.7 - $195.41 $312,729 - $366,589
-1,876 Reduced 0.52%
360,570 $66.4 Million
Q1 2019

May 15, 2019

SELL
$180.87 - $203.88 $115,575 - $130,279
-639 Reduced 0.18%
362,446 $68.9 Million
Q2 2018

Aug 02, 2018

SELL
$166.05 - $186.51 $70,239 - $78,893
-423 Reduced 0.12%
363,085 $67 Million
Q1 2018

May 10, 2018

SELL
$169.43 - $198.0 $220,767 - $257,994
-1,303 Reduced 0.36%
363,508 $62 Million
Q4 2017

Feb 06, 2018

BUY
$168.79 - $188.59 $49,286 - $55,068
292 Added 0.08%
364,811 $63.4 Million
Q3 2017

Nov 14, 2017

BUY
$167.29 - $191.0 $108,403 - $123,768
648 Added 0.18%
364,519 $67.9 Million
Q2 2017

Aug 14, 2017

BUY
N/A
363,871
363,871 $62.7 Million

Others Institutions Holding AMGN

About AMGEN INC


  • Ticker AMGN
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 534,931,008
  • Market Cap $169B
  • Description
  • Amgen Inc. discovers, develops, manufactures, and delivers human therapeutics worldwide. It focuses on inflammation, oncology/hematology, bone health, cardiovascular disease, nephrology, and neuroscience areas. The company's products include Enbrel to treat plaque psoriasis, rheumatoid arthritis, and psoriatic arthritis; Neulasta that reduces th...
More about AMGN
Track This Portfolio

Track Saturna Capital Corp Portfolio

Follow Saturna Capital Corp and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Saturna Capital Corp, based on Form 13F filings with the SEC.

News

Stay updated on Saturna Capital Corp with notifications on news.